2023
DOI: 10.1002/ags3.12719
|View full text |Cite
|
Sign up to set email alerts
|

Evaluating staging laparoscopy indications for pancreatic cancer based on resectability classification and treatment strategies for patients with positive peritoneal washing cytology

Abstract: IntroductionThe prognosis of pancreatic ductal adenocarcinoma (PDAC) in patients with positive peritoneal washing cytology (CY1) is poor. We aimed to evaluate the results of staging laparoscopy (SL) and treatment efficacy in CY1 patients based on a resectability classification.MethodsWe retrospectively reviewed 250 patients with PDAC who underwent SL before the initial treatment between 2017 and 2023 at the University of Toyama.ResultsThe breakdown of cases by resectability classification was resectable (R):bo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

2
3

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 39 publications
0
2
0
Order By: Relevance
“…Pancreatic cancer accounts for the majority of diseases requiring pancreatectomy. In recent years, advances in multidisciplinary treatment for pancreatic cancer have led to an increase in the 5‐year survival rate of pancreatic cancer patients and an increase in the number of patients who survive for a long period 6–9 . Therefore, we need to address mid‐ to long‐term complications after PD for stable and reliable continuation of postoperative chemotherapy.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Pancreatic cancer accounts for the majority of diseases requiring pancreatectomy. In recent years, advances in multidisciplinary treatment for pancreatic cancer have led to an increase in the 5‐year survival rate of pancreatic cancer patients and an increase in the number of patients who survive for a long period 6–9 . Therefore, we need to address mid‐ to long‐term complications after PD for stable and reliable continuation of postoperative chemotherapy.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, advances in multidisciplinary treatment for pancreatic cancer have led to an increase in the 5‐year survival rate of pancreatic cancer patients and an increase in the number of patients who survive for a long period. 6 , 7 , 8 , 9 Therefore, we need to address mid‐ to long‐term complications after PD for stable and reliable continuation of postoperative chemotherapy. However, various complications, such as pancreatic fistula and delayed gastric emptying, can occur in 10%–23% of patients after PD 10 , 11 and overwhelmingly cause the most frequent and troublesome aspects of all abdominal surgeries.…”
Section: Introductionmentioning
confidence: 99%